van Bragt JJMH, de Vries R, Sterk PJ, Maitland-van der Zee AH. Exhaled breath analysis for prediction of responders to mepolizumab in patients with severe asthma. Am J Resp Crit Care Med. 2019;199:A2673.
Benralizumab, dupilumab of mepolizumab: lagere SARS-CoV-2-immuniteit na vaccinatie
okt 2024 | Astma, Eczeem, Vaccinatie, Virale infecties